PT1042340E - Oxima de 6-o-alquil-eritromicina b - Google Patents
Oxima de 6-o-alquil-eritromicina bInfo
- Publication number
- PT1042340E PT1042340E PT98958055T PT98958055T PT1042340E PT 1042340 E PT1042340 E PT 1042340E PT 98958055 T PT98958055 T PT 98958055T PT 98958055 T PT98958055 T PT 98958055T PT 1042340 E PT1042340 E PT 1042340E
- Authority
- PT
- Portugal
- Prior art keywords
- alkyl
- eritromycin
- oxyme
- oxime erythromycin
- alkyl derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/980,918 US5932710A (en) | 1997-12-01 | 1997-12-01 | Process for preparing 6-O-alkyl-9-oxime erythromycin B |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1042340E true PT1042340E (pt) | 2004-12-31 |
Family
ID=25527956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98958055T PT1042340E (pt) | 1997-12-01 | 1998-11-17 | Oxima de 6-o-alquil-eritromicina b |
Country Status (13)
Country | Link |
---|---|
US (2) | US5932710A (pt) |
EP (1) | EP1042340B1 (pt) |
JP (1) | JP2001525331A (pt) |
KR (1) | KR20010032688A (pt) |
AT (1) | ATE277063T1 (pt) |
AU (1) | AU1417399A (pt) |
CA (1) | CA2309963C (pt) |
DE (1) | DE69826520T2 (pt) |
DK (1) | DK1042340T3 (pt) |
ES (1) | ES2229550T3 (pt) |
IL (1) | IL136088A0 (pt) |
PT (1) | PT1042340E (pt) |
WO (1) | WO1999028332A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003516999A (ja) * | 1999-12-16 | 2003-05-20 | テバ ファーマシューティカル インダストリーズ リミティド | クラリスロマイシン多型体の製法及び多型体iv |
KR20020071012A (ko) | 2000-01-11 | 2002-09-11 | 테바 파마슈티컬 인더스트리즈 리미티드 | 클래리스로마이신 다형체의 제조 방법 |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
PL366021A1 (en) | 2000-02-29 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6455680B1 (en) | 2000-12-21 | 2002-09-24 | Abbott Laboratories | Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
TWI246515B (en) | 2001-05-30 | 2006-01-01 | Abbott Lab | An arylation method for the functionalization of O-allyl erythromycin derivatives |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
US8425936B2 (en) | 2003-07-21 | 2013-04-23 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
JP2007502296A (ja) | 2003-08-11 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | ロバストペレット |
WO2005016278A2 (en) | 2003-08-12 | 2005-02-24 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
WO2005023184A2 (en) * | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
US8460710B2 (en) | 2003-09-15 | 2013-06-11 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
CA2572292A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
JPWO2007119717A1 (ja) * | 2006-04-13 | 2009-08-27 | 大正製薬株式会社 | アルドヘキソピラノース中間体の製造法 |
RU2455308C2 (ru) * | 2006-05-01 | 2012-07-10 | Тайсо Фармасьютикал Ко., Лтд. | Макролидные производные |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
EP2177526A4 (en) | 2007-08-06 | 2012-08-22 | Taisho Pharmaceutical Co Ltd | 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12 |
WO2009023191A2 (en) * | 2007-08-09 | 2009-02-19 | Teva Pharmaceutical Industries Ltd. | An improved process for the preparation of clarithromycin |
WO2009139181A1 (ja) | 2008-05-15 | 2009-11-19 | 大正製薬株式会社 | 4員環構造を有する10a-アザライド化合物 |
CN102082088B (zh) * | 2009-11-30 | 2012-04-18 | 上海华虹Nec电子有限公司 | 在直接化学机械抛光工艺的产品中共用sl掩模板的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3681326A (en) * | 1971-01-11 | 1972-08-01 | Abbott Lab | 9-substituted erythromycin a and b oximes |
US3855203A (en) * | 1973-05-03 | 1974-12-17 | Abbott Lab | 4{41 -o-sulfonyl erythromycin-9-o-oxime derivatives |
JPS5896097A (ja) * | 1981-12-01 | 1983-06-07 | Taisho Pharmaceut Co Ltd | エリスロマイシンb誘導体 |
JPS60214796A (ja) * | 1984-04-06 | 1985-10-28 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシン類の製法 |
JPS61103890A (ja) * | 1984-10-26 | 1986-05-22 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシンa誘導体 |
US4670549A (en) * | 1985-03-18 | 1987-06-02 | Taisho Pharmaceutical Co., Ltd. | Method for selective methylation of erythromycin a derivatives |
US5141926A (en) * | 1990-04-18 | 1992-08-25 | Abbott Laboratories | Erythromycin derivatives |
WO1993013780A1 (en) * | 1992-01-21 | 1993-07-22 | Abbott Laboratories | 4''-deoxyerythromycin derivatives |
-
1997
- 1997-12-01 US US08/980,918 patent/US5932710A/en not_active Expired - Lifetime
-
1998
- 1998-11-17 AT AT98958055T patent/ATE277063T1/de not_active IP Right Cessation
- 1998-11-17 JP JP2000523223A patent/JP2001525331A/ja active Pending
- 1998-11-17 DE DE69826520T patent/DE69826520T2/de not_active Expired - Fee Related
- 1998-11-17 PT PT98958055T patent/PT1042340E/pt unknown
- 1998-11-17 DK DK98958055T patent/DK1042340T3/da active
- 1998-11-17 CA CA002309963A patent/CA2309963C/en not_active Expired - Fee Related
- 1998-11-17 KR KR1020007005970A patent/KR20010032688A/ko not_active Application Discontinuation
- 1998-11-17 EP EP98958055A patent/EP1042340B1/en not_active Expired - Lifetime
- 1998-11-17 IL IL13608898A patent/IL136088A0/xx unknown
- 1998-11-17 WO PCT/US1998/024547 patent/WO1999028332A1/en active IP Right Grant
- 1998-11-17 AU AU14173/99A patent/AU1417399A/en not_active Abandoned
- 1998-11-17 ES ES98958055T patent/ES2229550T3/es not_active Expired - Lifetime
-
1999
- 1999-04-29 US US09/301,773 patent/US6194387B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1042340B1 (en) | 2004-09-22 |
EP1042340A1 (en) | 2000-10-11 |
ES2229550T3 (es) | 2005-04-16 |
ATE277063T1 (de) | 2004-10-15 |
DK1042340T3 (da) | 2004-11-29 |
KR20010032688A (ko) | 2001-04-25 |
AU1417399A (en) | 1999-06-16 |
CA2309963A1 (en) | 1999-06-10 |
US5932710A (en) | 1999-08-03 |
CA2309963C (en) | 2008-06-17 |
US6194387B1 (en) | 2001-02-27 |
DE69826520D1 (en) | 2004-10-28 |
DE69826520T2 (de) | 2005-12-01 |
IL136088A0 (en) | 2001-05-20 |
WO1999028332A1 (en) | 1999-06-10 |
JP2001525331A (ja) | 2001-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1042340E (pt) | Oxima de 6-o-alquil-eritromicina b | |
DK0891371T3 (da) | 9-oximsilylerythromycin A derivater | |
UA27105A1 (uk) | О-метильhі похідhі азитроміциhу а, що мають аhтибактеріальhу активhість, спосіб їх отримаhhя та проміжhі сполуки | |
SI0680967T1 (en) | Erythromycin derivatives, their process of preparation and their use as medicaments | |
NO951198D0 (no) | Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene | |
AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
AP9801253A0 (en) | 9-Oxime erythromycin derivatives. | |
NZ337246A (en) | Pharmaceutical composition comprising amoxycillin and clavulanate | |
NZ219015A (en) | Thieno-1,4-diazepine derivatives and pharmaceutical compositions:intermediates in their preparation | |
ATE71113T1 (de) | Antibiotikum a 40926 mannosyl aglycon. | |
ATE186541T1 (de) | Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung | |
TR199900661T2 (xx) | Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m� | |
MY101178A (en) | Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon | |
DK312688A (da) | Glykkopeptid-antibiotika | |
IS6559A (is) | Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum | |
AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
PL324690A1 (en) | Improved therapeutic agents | |
LV12172A (lv) | Kompozicija organu kriokonservesanai um virusu un bakterialas infekcijas arstesanai | |
FI944563A0 (fi) | Mikro-organismeja, valmistusmenetelmä ja käyttö | |
AP9801235A0 (en) | Erythromycin derivatives. | |
ZA9711101B (en) | Derivatives of erythromycin their preparation process and their use as medicaments | |
EG18213A (en) | Pharmaceutical formulation for the treatment of bacterial infections | |
IL115197A (en) | Vaccine preparations for preventing vaginal infections | |
NO961429D0 (no) | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater | |
NO178302C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte 3-tia- henholdsvis 3-oksa-alkylflavoner, samt mellomprodukter for fremgangsmåten |